**Core Concept**
Tacrolimus is a potent immunosuppressive calcineurin inhibitor used to prevent organ rejection in transplant patients. It works by inhibiting the activation of T-lymphocytes, which play a crucial role in the immune response.

**Why the Correct Answer is Right**
Tacrolimus binds to FKBP-12 (FK506 binding protein), a cytosolic receptor, and this complex inhibits the phosphatase activity of calcineurin. Calcineurin is essential for the activation of T-lymphocytes by dephosphorylating and thereby activating the nuclear factor of activated T-cells (NFAT). The inhibition of calcineurin prevents the transcription of IL-2 and other cytokines, leading to the suppression of the immune response. Tacrolimus is primarily metabolized by CYP3A enzymes in the liver.

**Why Each Wrong Option is Incorrect**
**Option A:** Tacrolimus is not a corticosteroid, which is a different class of immunosuppressive agents. Corticosteroids, such as prednisolone, work by suppressing the inflammatory response and are not as potent as calcineurin inhibitors like tacrolimus.

**Option B:** Tacrolimus is indeed a calcineurin inhibitor, and its mechanism of action is through the inhibition of calcineurin, as explained above.

**Option C:** Tacrolimus is not a monoclonal antibody, which is a different class of immunosuppressive agents. Monoclonal antibodies, such as basiliximab, work by binding to specific antigens on the surface of immune cells and preventing their activation.

**Option D:** Tacrolimus is not a mTOR inhibitor, which is a different class of immunosuppressive agents. mTOR inhibitors, such as sirolimus, work by inhibiting the mammalian target of rapamycin (mTOR) pathway, which is involved in cell growth and proliferation.

**Clinical Pearl / High-Yield Fact**
Tacrolimus is known for its narrow therapeutic index, which means that the difference between the effective dose and the toxic dose is small. Monitoring of tacrolimus levels is essential to avoid toxicity, which can manifest as nephrotoxicity, neurotoxicity, or hypertension.

**Correct Answer: D. Tacrolimus is not a mTOR inhibitor, which is a different class of immunosuppressive agents.**